Sven Michel
Overview
Explore the profile of Sven Michel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Prill R, Becker R, Schulz R, Michel S, Hommel H
Knee Surg Sports Traumatol Arthrosc
. 2021 Apr;
30(9):3155-3161.
PMID: 33881572
Purpose: Standardized outcome measures are crucial for the evaluation of different treatment and rehabilitation regimes in patients after total knee arthroplasty (TKA). Performance-based measures are necessary to capture different aspects...
12.
Michel S, Schirduan K, Shen Y, Klar R, Tost J, Jaschinski F
Mol Diagn Ther
. 2020 Dec;
25(1):77-85.
PMID: 33314011
Background: The field of antisense oligonucleotide therapeutics is rapidly growing and in addition to small molecules and therapeutic antibodies, oligonucleotide-based gene expression modifiers have been developed as fully accepted therapeutics....
13.
Suliga E, Ciesla E, Michel S, Kaducakova H, Martin T, Sliwinski G, et al.
Int J Environ Res Public Health
. 2020 Dec;
17(23).
PMID: 33291705
The eating habits of students differ significantly from those recommended by health practitioners. The aim of this study was to find differences related to diet quality and knowledge on nutrition...
14.
Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis
Shen M, Xie S, Rowicki M, Michel S, Wei Y, Hang X, et al.
Cancer Res
. 2020 Nov;
81(4):1014-1025.
PMID: 33239430
Colorectal and lung cancers account for one-third of all cancer-related deaths worldwide. Previous studies suggested that metadherin (MTDH) is involved in the development of colorectal and lung cancers. However, how...
15.
Festag J, Thelemann T, Schell M, Raith S, Michel S, Jaschinski F, et al.
Mol Ther Nucleic Acids
. 2020 Aug;
21:656-669.
PMID: 32739778
The adenosine axis contributes to the suppression of antitumor immune responses. The ectonucleotidase CD39 degrades extracellular adenosine triphosphate (ATP) to adenosine monophosphate (AMP), which is degraded to adenosine by CD73....
16.
Prill R, Singh J, Seeber G, Nielsen S, Goodman S, Michel S, et al.
BMJ Open
. 2020 Jun;
10(6):e035207.
PMID: 32595152
Introduction: There is a lack of harmonising measures for clinical trials on total joint replacement (TJR) that would allow for results from TJR studies to be compared or pooled. The...
17.
Klar R, Michel S, Schell M, Hinterwimmer L, Zippelius A, Jaschinski F
Cancer Immunol Immunother
. 2019 Dec;
69(1):57-67.
PMID: 31802183
Tumors can utilize a diverse repertoire of immunosuppressive mechanisms to evade attack by the immune system. Despite promising success with blockade of immune checkpoints like PD-1 the majority of patients...
18.
Cao Y, Trillo-Tinoco J, Sierra R, Anadon C, Dai W, Mohamed E, et al.
Nat Commun
. 2019 Aug;
10(1):3680.
PMID: 31417079
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
19.
Sadewasser A, Dietzel E, Michel S, Kluver M, Helfer M, Thelemann T, et al.
Mol Ther Nucleic Acids
. 2019 May;
16:686-697.
PMID: 31125846
Ebola virus is the causative agent of Ebola virus disease, a severe, often fatal illness in humans. So far, there are no US Food and Drug Administration (FDA)-approved therapeutics directed...
20.
Gaertner V, Michel S, Curtin J, Pulkkinen V, Acevedo N, Soderhall C, et al.
Pediatr Pulmonol
. 2019 Mar;
54(6):847-857.
PMID: 30927345
Background: Neuropeptide S Receptor 1 ( NPSR1) and Retinoid Acid Receptor-Related Orphan Receptor Alpha (RORA ) interact biologically, are both known candidate genes for asthma, and are involved in controlling...